
CG Oncology CEO Arthur Kuan buys $2.4 million of shares
Open market purchase reported on Form 4, filed Nov 18, 2026.
Snapshot
Arthur Kuan, Chief Executive Officer of CG Oncology (CGON), bought 30,000.32 shares in open market purchases on Nov 18, 2026, about $2.4 million at an average price of $78.88 a share, according to a Form 4 filed with the SEC on Nov 18, 2026.
- Independent Research
Market Data
| Company | 1D % | Price |
|---|---|---|
| ($CGON) | ▼ −1.26% | 80.87 |
as of 12:33 ET · Realtime derived data
What We Know
The filing lists 1 open market purchase line: • Nov 18, 2026: 30,000.32 shares at $78.88.
After the last purchase, the filing reports 228,916.32 shares held directly in that account.
Octans View
The purchases raised the holding reported in that account by about 15%, computed from the filed share counts. An open market purchase is made with the insider's own money at the market price, unlike option exercises or stock awards, which this brief excludes. The filing does not say why the insider bought.
Bear Case · Room for Disagreement
Limits. Insiders must report trades within two business days; this brief covers one filing and does not net it against sales by the same person or other insiders. Prices are as filed; where a line shows a weighted average, the filing's footnotes give the range.
Method and source. Octans Research reads the structured Form 4 filed with the SEC, keeps open market purchases (code P) only, and computes the total value and the average price from the filed share counts and prices. The filed price must sit within 25% of the closing price on the trade date. The text is generated by a fixed template; no model wrote it.
Chart
Sources
- [1]SEC EDGAR — Form 4 filed by Arthur Kuan for CG Oncology, Nov 18, 2026
These are the sources this piece was drafted from. How we verify. Found an error? Tell us and we correct it in public.
$2.4M
More on $CGON
4 reports
Itt director Kevin C Berryman buys $502,000 of shares
Open market purchase reported on Form 4, filed Nov 19, 2026.
Coastal Financial director Steven D Hovde buys $550,000 of shares
Open market purchase reported on Form 4, filed Nov 19, 2026.
Prologis director Alfred F Kelly Jr buys $587,000 of shares
Open market purchase reported on Form 4, filed Nov 19, 2026.
iRhythm director Abhijit Y Talwalkar buys $764,000 of shares
Open market purchase reported on Form 4, filed Nov 19, 2026.